30.49
前日終値:
$30.09
開ける:
$30.42
24時間の取引高:
584.85K
Relative Volume:
0.40
時価総額:
$1.94B
収益:
-
当期純損益:
$-107.85M
株価収益率:
-13.80
EPS:
-2.21
ネットキャッシュフロー:
$-106.82M
1週間 パフォーマンス:
-1.44%
1か月 パフォーマンス:
+28.29%
6か月 パフォーマンス:
+35.96%
1年 パフォーマンス:
-28.62%
Vera Therapeutics Inc Stock (VERA) Company Profile
名前
Vera Therapeutics Inc
セクター
電話
650-770-0077
住所
2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE
VERA を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
VERA
Vera Therapeutics Inc
|
30.47 | 1.92B | 0 | -107.85M | -106.82M | -2.21 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
408.08 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
471.75 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
561.49 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
804.49 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
328.98 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Vera Therapeutics Inc Stock (VERA) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-08-04 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
2025-05-05 | 再開されました | H.C. Wainwright | Buy |
2025-02-04 | 開始されました | Wolfe Research | Outperform |
2025-01-28 | 開始されました | Goldman | Buy |
2024-11-21 | 開始されました | Wells Fargo | Overweight |
2024-10-16 | 開始されました | Scotiabank | Sector Outperform |
2024-01-25 | 開始されました | Oppenheimer | Outperform |
2024-01-08 | 開始されました | Cantor Fitzgerald | Overweight |
2023-12-18 | 開始されました | Raymond James | Outperform |
2023-11-10 | アップグレード | Jefferies | Hold → Buy |
2023-08-16 | 開始されました | Guggenheim | Buy |
2023-01-04 | ダウングレード | Jefferies | Buy → Hold |
2023-01-04 | ダウングレード | Wedbush | Outperform → Neutral |
2022-07-12 | 開始されました | JP Morgan | Overweight |
2022-05-02 | 開始されました | H.C. Wainwright | Buy |
2022-04-19 | 開始されました | Wedbush | Outperform |
すべてを表示
Vera Therapeutics Inc (VERA) 最新ニュース
Can Vera Therapeutics Inc. hit a new high this monthBond Market & Consistent Profit Trade Alerts - newser.com
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(4) - MarketScreener
Is Vera Therapeutics Inc. stock overvalued by current metricsJuly 2025 Levels & Reliable Breakout Forecasts - newser.com
Vera Therapeutics Inc. stock trend forecastCPI Data & High Return Stock Watch Alerts - newser.com
Is Vera Therapeutics Inc a good long term investmentBear Market Strategies & Follow Top Performers in the Community - earlytimes.in
Ranking Vera Therapeutics Inc. among high performing stocks via toolsJuly 2025 Weekly Recap & Free Daily Entry Point Trade Alerts - newser.com
Why Vera Therapeutics Inc. stock could rally in 2025Portfolio Return Report & Accurate Buy Signal Notifications - newser.com
Vera started at buy by Goldman Sachs, atacicept potential cited - MSN
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Trend analysis for Vera Therapeutics Inc. this weekTrade Risk Report & Community Consensus Stock Picks - newser.com
Detecting support and resistance levels for Vera Therapeutics Inc.2025 Dividend Review & Fast Entry Momentum Alerts - newser.com
Vera Therapeutics' (VERA) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
Polycythemia Vera Pipeline 2025: FDA Updates, Therapy - openPR.com
What indicators show strength in Vera Therapeutics Inc.Portfolio Gains Summary & Technical Pattern Alert System - newser.com
Using RSI to spot recovery in Vera Therapeutics Inc.2025 Trading Volume Trends & Fast Moving Market Watchlists - newser.com
Heatmap analysis for Vera Therapeutics Inc. and competitorsBear Alert & AI Powered Buy and Sell Recommendations - newser.com
Will Vera Therapeutics Inc. stock remain a Wall Street favoriteJuly 2025 WrapUp & Verified Chart Pattern Trade Signals - newser.com
Risk vs reward if holding onto Vera Therapeutics Inc.2025 Top Gainers & High Accuracy Swing Trade Signals - newser.com
J. Safra Sarasin Holding AG Takes Position in Vera Therapeutics, Inc. $VERA - MarketBeat
Evaluating Vera Therapeutics Inc. with trendline analysisJuly 2025 Outlook & AI Powered Trade Plan Recommendations - newser.com
Developing predictive dashboards with Vera Therapeutics Inc. dataJuly 2025 Snapshot & AI Powered Trade Plan Recommendations - newser.com
What drives Vera Therapeutics Inc stock priceLong-Term Growth Stocks & These Stocks Are Just Getting Started - earlytimes.in
Evercore Maintains Vera Therapeutics(VERA.US) With Buy Rating, Maintains Target Price $75 - 富途牛牛
Vera Therapeutics, Inc. $VERA Shares Purchased by Platinum Investment Management Ltd. - MarketBeat
13,567 Shares in Vera Therapeutics, Inc. $VERA Acquired by GC Wealth Management RIA LLC - MarketBeat
Fifth Third Bancorp Buys New Stake in Vera Therapeutics, Inc. $VERA - Defense World
10,406 Shares in Vera Therapeutics, Inc. $VERA Purchased by Perigon Wealth Management LLC - MarketBeat
J.P. Morgan Maintains Vera Therapeutics(VERA.US) With Buy Rating - 富途牛牛
What analysts say about Vera Therapeutics Inc stockDividend Reinvestment Plans & Low Risk Investment Tips - earlytimes.in
Vera Therapeutics Inc Stock Analysis and ForecastHigh Beta Stocks & Small Entry Investment Ideas - Early Times
Vera Therapeutics, Inc. (NASDAQ:VERA) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Vera Therapeutics (NASDAQ:VERA) Shares Up 5.3%Time to Buy? - MarketBeat
Vera Therapeutics (VERA): Assessing Valuation After New KDIGO Guidelines Shape the IgA Nephropathy Market - Sahm
Vera Therapeutics Inc (VERA) 財務データ
収益
当期純利益
現金流量
EPS
Vera Therapeutics Inc (VERA) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
ENRIGHT PATRICK G | Director |
Jun 24 '25 |
Buy |
22.35 |
40,607 |
907,635 |
3,596,593 |
Fordyce Marshall | PRESIDENT AND CEO |
Feb 21 '25 |
Sale |
27.89 |
10,613 |
296,032 |
213,740 |
Fordyce Marshall | PRESIDENT AND CEO |
Feb 26 '25 |
Sale |
27.65 |
9,075 |
250,882 |
204,665 |
大文字化:
|
ボリューム (24 時間):